Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2015 (2015), Article ID 613045, 7 pages
http://dx.doi.org/10.1155/2015/613045
Research Article

Multiple Myeloma Patients at Various Cytogenetic Risks Benefit Differently from Autologous Stem Cell Transplantation as a Consolidation Therapy

Department of Hematology, The Myeloma and Lymphoma Center, Changzheng Hospital, The Second Military Medical University, 415 Fengyang Road, Shanghai 200003, China

Received 28 October 2014; Revised 14 December 2014; Accepted 5 January 2015

Academic Editor: Boon Chin Heng

Copyright © 2015 Tianmei Zeng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Tianmei Zeng, Lili Zhou, Hao Xi, et al., “Multiple Myeloma Patients at Various Cytogenetic Risks Benefit Differently from Autologous Stem Cell Transplantation as a Consolidation Therapy,” Stem Cells International, vol. 2015, Article ID 613045, 7 pages, 2015. doi:10.1155/2015/613045